Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy during SARS-CoV-2 Infection and Vaccination.

Vaccines (Basel) · 2023 · PMC9962518 · PMID 36851351

Europe PMC DOI

hedged sentence

0.1300

closest p · 2.6× alpha

0.1300

boldest claim

The sentences

did not reach statistical significancep = 0.13not close (p > 0.1)

The patients who developed AMN and PAMM after COVID-19 vaccinations were relatively younger than the cohort with COVID-19 infection, though it did not reach statistical significance (32.04 ± 13.2 years versus 36.7 ± 14.4 years; p = 0.13).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.